Synergistic local combination of radiation and anti-programmed death ligand 1 immunotherapy using radiation-responsive splintery metallic nanocarriers

INIS

• radiotherapy 80%
• death 50%
• immunotherapy 50%
• ligands 50%
• radiations 20%
• tumors 20%
• nanocrystals 20%
• nanostructures 10%
• toxicity 10%
• conversion 10%
• apoptosis 10%
• cargo 10%
• deformation 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Radiation 100%
• Immunotherapy 50%
• Programmed Death 1 Ligand 1 50%
• Nanocrystal 20%
• Nanocarrier 20%
• Toxicity 10%
• Neoplasm 10%
• Adverse Event 10%
• Nanomaterial 10%
• Tumor Microenvironment 10%
• Cell Death 10%
• Immunogenicity 10%